GI Innovation transfers technology to Japan for allergy treatment drug for 298 billion won = South Korean report

On the 16th, South Korean pharmaceutical company GI Innovation transferred technology for the allergy treatment drug "GI-301" to Japanese peer Maruho for approximately 298 billion won (approximately 32,920,770,000 yen).